v3.23.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Operating expenses:        
Research and development $ 252,880 $ 153,389 $ 460,214 $ 446,440
General and administrative 4,094,664 674,570 7,612,154 1,239,772
Total operating expenses 4,347,544 827,959 8,072,368 1,686,212
Loss from operations (4,347,544) (827,959) (8,072,368) (1,686,212)
Other income (expense):        
Foreign exchange transaction loss 0 0 (935) 0
Change in fair value of share liability 60,100 0 170,385 0
Interest income 1,098 789 1,494 1,454
Total other income 61,198 789 170,944 1,454
Net loss $ (4,286,346) $ (827,170) $ (7,901,424) $ (1,684,758)
Net loss per share, basic and diluted $ (0.14) $ (0.03) $ (0.27) $ (0.07)
Weighted average shares of common stock outstanding, basic and diluted 29,796,065 27,109,754 29,535,060 25,798,098
Other comprehensive loss:        
Net loss $ (4,286,346) $ (827,170) $ (7,901,424) $ (1,684,758)
Foreign currency translation (472,673) 354,528 (1,476,526) 125,271
Total comprehensive loss $ (4,759,019) $ (472,642) $ (9,377,950) $ (1,559,487)

Source